14.32
Carlsmed Inc stock is traded at $14.32, with a volume of 7,105.
It is up +3.39% in the last 24 hours and down -5.98% over the past month.
Carlsmed Inc is a commercial-stage medical technology company focused on developing AI-enabled personalized solutions for spine surgery. The company operates as a single operating and reportable segment engaged in the design, manufacture, and marketing of its Aprevo technology platform, which provides customized surgical planning and implants for lumbar and cervical spine fusion procedures, mainly sold to hospitals and ambulatory surgical centers.
See More
Previous Close:
$13.85
Open:
$13.91
24h Volume:
7,105
Relative Volume:
0.08
Market Cap:
$390.98M
Revenue:
$56.44M
Net Income/Loss:
$-32.60M
P/E Ratio:
-11.63
EPS:
-1.2318
Net Cash Flow:
$-35.15M
1W Performance:
+1.92%
1M Performance:
-5.98%
6M Performance:
+30.78%
1Y Performance:
+4.91%
Carlsmed Inc Stock (CARL) Company Profile
Name
Carlsmed Inc
Sector
Industry
Phone
858-295-9290
Address
1800 ASTON AVENUE, CARLSBAD
Compare CARL vs VEEV, TEM, BTSG, HNGE, HQY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
CARL
Carlsmed Inc
|
14.32 | 390.98M | 56.44M | -32.60M | -35.15M | -1.2318 |
|
VEEV
Veeva Systems Inc
|
312.67 | 50.62B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
TEM
Tempus Ai Inc
|
69.31 | 12.58B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
BTSG
Brightspring Health Services Inc
|
62.42 | 12.35B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
HNGE
Hinge Health Inc
|
105.31 | 8.50B | 646.34M | -512.40M | 202.76M | -6.6871 |
|
HQY
Healthequity Inc
|
92.42 | 7.64B | 1.34B | 230.70M | 440.96M | 2.6695 |
Carlsmed Inc Stock (CARL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-01-26 | Initiated | Needham | Buy |
| Aug-18-25 | Initiated | BTIG Research | Buy |
| Aug-18-25 | Initiated | BofA Securities | Buy |
| Aug-18-25 | Initiated | Goldman | Buy |
| Aug-18-25 | Initiated | Piper Sandler | Overweight |
| Aug-18-25 | Initiated | Truist | Buy |
View All
Carlsmed Inc Stock (CARL) Latest News
Carlsmed Officer Jeffrey Bertolini Files Form 144 to Sell 747 Shares Acquired via Stock Option - Kalkine Media
Carlsmed, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Form 4 Carlsmed Inc For: 2 October By Investing.com - Investing.com South Africa
Form 4 Carlsmed Inc For: 2 October By Investing.com - Investing.com Canada
At $13.99 a share, Carlsmed (CARL) COO sells 243 shares under a prearranged trading plan. - Stock Titan
Form 4 Carlsmed Inc For: 30 September By Investing.com - Investing.com South Africa
Form 4 Carlsmed Inc For: 30 September By Investing.com - Investing.com UK
Stock awards for Carlsmed (CARL)'s CFO include 89,286 units and options exercisable at $14.18. - Stock Titan
Presidio Management Group XII buys $3m in Carlsmed stock By Investing.com - Investing.com India
Presidio Management Group XII buys $3m in Carlsmed stock By Investing.com - Investing.com Canada
Presidio Management Group XII buys $3m in Carlsmed stock - Investing.com
Ten percent owner boosts stake in Carlsmed (CARL) - Stock Titan
Carlsmed COO Jeffrey Bertolini Awarded 50,000 Stock Options with $15.23 Exercise Price - Kalkine Media
Carlsmed (CARL) awards COO 50,000 stock options - Stock Titan
Carlsmed (CARL) COO discloses 22,489-share stake - Stock Titan
Carlsmed, Inc.: Shareholders Board Members Managers and Company Profile | US14280C1053 - marketscreener.com
Carlsmed appoints Jeff Bertolini as new COO - TipRanks
Carlsmed, Inc. Announces Chief Operating Officer Appointment - The Manila Times
Carlsmed names Jeffrey Bertolini as Chief Operating Officer - TradingView
Carlsmed, Inc. Announces Chief Operating Officer Appointment - marketscreener.com
Carlsmed, Inc. Announces Chief Operating Officer Appointment - Yahoo Finance
symbol__ Stock Quote Price and Forecast - cnn.com
BlackRock Inc. Purchases New Holdings in Carlsmed, Inc. $CARL - MarketBeat
Jupiter Topco LLC Acquires New Holdings in Carlsmed, Inc. $CARL - MarketBeat
Wall Street Analysts Think Carlsmed, Inc. (CARL) Could Surge 90.77%: Read This Before Placing a Bet - qz.com
Parkman Healthcare Partners LLC Invests $6.20 Million in Carlsmed, Inc. $CARL - MarketBeat
Carlsmed (CARL) Earnings Snapshot: EPS Lands Above Forecast on the Day; The Stock Ends Down 1.56% in the Current UpdateDividend Growth Analysis - dars.gov.et
Carlsmed, Inc. (NASDAQ:CARL) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Wall Street Zen Upgrades Carlsmed (NASDAQ:CARL) to "Hold" - MarketBeat
Carlsmed (CARL) plans up to $250M in stock, debt and warrant sales - Stock Titan
Carlsmed (CARL) Holds Steady Near $13.72 as Tight Range Signals Potential MoveDefined Outcome ETF - vinanet.vn
Carlsmed (CARL) Holds Steady Near $13.72 as Tight Range Signals Potential MoveBearish Sentiment - dars.gov.et
Carlsmed Eyes Growth as Cervical Launch, Medicare Shift Boost Spine Platform - TradingView
Carlsmed Eyes Growth as Cervical Launch, Medicare Shift Boost Spine Platform - TradingView
Transcript : Carlsmed, Inc. Presents at Bank of America SMID Cap Virtual Conference, Aug-12-2026 11 - marketscreener.com
CARL: Personalized AI spine surgery platform accelerates growth with new reimbursement and strong clinical data - TradingView
CARL Q2 2026 Earnings: Narrower-Than-Expected Loss but Shares Slip 2.55%Tax Rate Impact - vinanet.vn
Carlsmed, Inc. Common Stock (NASDAQ: CARL) Share Price, CARL Stock News, CARL Share Price & Updates - kalkine.ca
Carlsmed, Inc. Common Stock (NASDAQ: CARL) Share Price, CARL Stock News, CARL Share Price & Updates - Kalkine
Truist raises Carlsmed stock price target on strong growth outlook By Investing.com - Investing.com South Africa
Carlsmed Buy Rating Reaffirmed as 2026 Outlook Raised and Adoption Grows; $17 Price Target Maintained - TipRanks
Analysts Are Bullish on These NA Stocks: BillionToOne, Inc. Class A (BLLN), Carlsmed, Inc. (CARL) - theglobeandmail.com
Carlsmed Q2 2026 revenue up 57% to USD 18.9M - Medical Buyer
Truist raises Carlsmed stock price target on strong growth outlook - Investing.com Nigeria
CARLSMED INC Q2 NET INCOME USD -10.5 MILLION - Moomoo
Truist raises Carlsmed stock price target on strong growth outlook - Investing.com
Truist Adjusts Price Target on Carlsmed to $20 From $18, Maintains Buy Rating - marketscreener.com
Carlsmed, Inc. Stock 12‑Month Price Target Raised to $19.2, Implies 42% Upside - TradingView
Carlsmed Inc. (CARL) Advances 4.79% to $14.21: Personalized Spine Tech Gains TractionBuy Signal Reports - dars.gov.et
Carlsmed Inc (CARL) (Q2 2026) Earnings Call Highlights: Revenue Surges 57% to $18. ... - Yahoo Finance UK
Carlsmed Inc Stock (CARL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Carlsmed Inc Stock (CARL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Bertolini Jeffrey | Chief Operating Officer |
Oct 05 '26 |
Sale |
14.39 |
747 |
10,749 |
22,489 |
| Bertolini Jeffrey | Chief Operating Officer |
Oct 05 '26 |
Option Exercise |
5.92 |
747 |
4,419 |
23,236 |
| Bertolini Jeffrey | Officer |
Oct 05 '26 |
Proposed Sale |
14.39 |
747 |
10,749 |
0 |
| Bertolini Jeffrey | Officer |
Sep 30 '26 |
Proposed Sale |
13.99 |
243 |
3,400 |
0 |
| Bertolini Jeffrey | Chief Operating Officer |
Sep 30 '26 |
Sale |
13.99 |
243 |
3,400 |
22,489 |
| Bertolini Jeffrey | Chief Operating Officer |
Sep 30 '26 |
Option Exercise |
2.23 |
243 |
542 |
22,732 |
| Cordonnier Michael | CEO, President |
Mar 03 '26 |
Option Exercise |
1.02 |
193,831 |
198,555 |
1,550,477 |
| Cordonnier Michael | CEO, President |
Mar 02 '26 |
Sale |
13.29 |
197,855 |
2,629,889 |
1,356,646 |
| Cordonnier Michael | Officer |
Mar 02 '26 |
Proposed Sale |
13.29 |
197,855 |
2,629,881 |
0 |
| Cordonnier Michael | CEO, President |
Mar 02 '26 |
Option Exercise |
0.34 |
197,855 |
66,281 |
1,554,501 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):